Cargando…

Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant

BACKGROUND: This study aimed to investigate retinal imaging biomarkers, such as disorganization of the retinal inner layers (DRIL) and/or ellipsoid zone (EZ) disruption by spectral domain optical coherence tomography (SD-OCT), and functional outcomes in eyes treated with 0.2 µg/day of a fluocinolone...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes, Beatriz Oliveira, Brizido, Margarida Sena, Aerts, Florence, Pina, Susana Morais, Simoes, Pedro Santana, Miranda, Margarida Isidoro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Virtual Ophthalmic Research Center 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460228/
https://www.ncbi.nlm.nih.gov/pubmed/37641614
http://dx.doi.org/10.51329/mehdioph-thal1421
_version_ 1785097597632905216
author Lopes, Beatriz Oliveira
Brizido, Margarida Sena
Aerts, Florence
Pina, Susana Morais
Simoes, Pedro Santana
Miranda, Margarida Isidoro
author_facet Lopes, Beatriz Oliveira
Brizido, Margarida Sena
Aerts, Florence
Pina, Susana Morais
Simoes, Pedro Santana
Miranda, Margarida Isidoro
author_sort Lopes, Beatriz Oliveira
collection PubMed
description BACKGROUND: This study aimed to investigate retinal imaging biomarkers, such as disorganization of the retinal inner layers (DRIL) and/or ellipsoid zone (EZ) disruption by spectral domain optical coherence tomography (SD-OCT), and functional outcomes in eyes treated with 0.2 µg/day of a fluocinolone acetonide intravitreal implant (FAc) after an insufficient response to previous treatments. METHODS: This was a retrospective comparative study of 18 eyes (15 patients) with persistent and/or recurrent diabetic macular edema (DME) treated with FAc. Eyes were divided according to the number of prior intravitreal treatments: group 1 (n = 8) with ≤ 6 injections (early switch) and group 2 (n = 10) with > 6 injections (late switch). Outcomes included percentage of eyes with DRIL and/or EZ disruption at baseline and analysis of the best corrected visual acuity (BCVA) using ETDRS letters, central macular thickness (CMT), DRIL, and EZ disruption at the last observation. RESULTS: Group 2 revealed a significantly higher percentage of DRIL and/or EZ disruption than group 1 (P < 0.05). At the last observation, group 1 revealed a higher percentage of eyes achieving vision stability/ improvement, gaining ≥ 15 letters, and achieving ≥70 letters (P > 0.05 for all comparisons). The mean BCVA gain was 8.8 and 0.7 letters for groups 1 and 2 (P = 0.397). Both groups revealed a significant mean CMT reduction (> 20% reduction from the baseline value), without a significant statistical difference between them (P = 0.749). After treatment, most eyes from both groups showed resolution of DRIL and EZ disruption. CONCLUSIONS: Patients with DME presenting with a lower percentage of DRIL and/or EZ disruption at baseline had better functional outcomes, supporting the possible benefit of an early switch to FAc after insufficient response to previous treatments. Future randomized studies with a larger patient cohort are warranted to confirm our conclusions.
format Online
Article
Text
id pubmed-10460228
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Virtual Ophthalmic Research Center
record_format MEDLINE/PubMed
spelling pubmed-104602282023-08-28 Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant Lopes, Beatriz Oliveira Brizido, Margarida Sena Aerts, Florence Pina, Susana Morais Simoes, Pedro Santana Miranda, Margarida Isidoro Med Hypothesis Discov Innov Ophthalmol Article BACKGROUND: This study aimed to investigate retinal imaging biomarkers, such as disorganization of the retinal inner layers (DRIL) and/or ellipsoid zone (EZ) disruption by spectral domain optical coherence tomography (SD-OCT), and functional outcomes in eyes treated with 0.2 µg/day of a fluocinolone acetonide intravitreal implant (FAc) after an insufficient response to previous treatments. METHODS: This was a retrospective comparative study of 18 eyes (15 patients) with persistent and/or recurrent diabetic macular edema (DME) treated with FAc. Eyes were divided according to the number of prior intravitreal treatments: group 1 (n = 8) with ≤ 6 injections (early switch) and group 2 (n = 10) with > 6 injections (late switch). Outcomes included percentage of eyes with DRIL and/or EZ disruption at baseline and analysis of the best corrected visual acuity (BCVA) using ETDRS letters, central macular thickness (CMT), DRIL, and EZ disruption at the last observation. RESULTS: Group 2 revealed a significantly higher percentage of DRIL and/or EZ disruption than group 1 (P < 0.05). At the last observation, group 1 revealed a higher percentage of eyes achieving vision stability/ improvement, gaining ≥ 15 letters, and achieving ≥70 letters (P > 0.05 for all comparisons). The mean BCVA gain was 8.8 and 0.7 letters for groups 1 and 2 (P = 0.397). Both groups revealed a significant mean CMT reduction (> 20% reduction from the baseline value), without a significant statistical difference between them (P = 0.749). After treatment, most eyes from both groups showed resolution of DRIL and EZ disruption. CONCLUSIONS: Patients with DME presenting with a lower percentage of DRIL and/or EZ disruption at baseline had better functional outcomes, supporting the possible benefit of an early switch to FAc after insufficient response to previous treatments. Future randomized studies with a larger patient cohort are warranted to confirm our conclusions. International Virtual Ophthalmic Research Center 2021-08-05 /pmc/articles/PMC10460228/ /pubmed/37641614 http://dx.doi.org/10.51329/mehdioph-thal1421 Text en © Author(s). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Article
Lopes, Beatriz Oliveira
Brizido, Margarida Sena
Aerts, Florence
Pina, Susana Morais
Simoes, Pedro Santana
Miranda, Margarida Isidoro
Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant
title Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant
title_full Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant
title_fullStr Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant
title_full_unstemmed Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant
title_short Prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant
title_sort prognostic biomarkers of chronic diabetic macular edema treated with a fiuocinolone acetonide intravitreal implant
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460228/
https://www.ncbi.nlm.nih.gov/pubmed/37641614
http://dx.doi.org/10.51329/mehdioph-thal1421
work_keys_str_mv AT lopesbeatrizoliveira prognosticbiomarkersofchronicdiabeticmacularedematreatedwithafiuocinoloneacetonideintravitrealimplant
AT brizidomargaridasena prognosticbiomarkersofchronicdiabeticmacularedematreatedwithafiuocinoloneacetonideintravitrealimplant
AT aertsflorence prognosticbiomarkersofchronicdiabeticmacularedematreatedwithafiuocinoloneacetonideintravitrealimplant
AT pinasusanamorais prognosticbiomarkersofchronicdiabeticmacularedematreatedwithafiuocinoloneacetonideintravitrealimplant
AT simoespedrosantana prognosticbiomarkersofchronicdiabeticmacularedematreatedwithafiuocinoloneacetonideintravitrealimplant
AT mirandamargaridaisidoro prognosticbiomarkersofchronicdiabeticmacularedematreatedwithafiuocinoloneacetonideintravitrealimplant